Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hochschild Mining appoints Vale veteran Cassio Diedrich as COO

(Sharecast News) - Hochschild Mining said on Tuesday that it has appointed Cassio Diedrich as chief operating officer. The appointment took effect on Monday. Hochschild said Diedrich is an experienced mining engineer who began his career at Vale, where he held a number of senior responsibilities including technical, operational and business roles over 15 years, latterly as global head of mining & technical services for the Vale base metals business.

Recently, Diedrich held the role of head of business planning and mining at Glencore for two years before becoming Kinterra Capital's global head of strategy & portfolio companies.

Hochschild said he is a Brazilian national whose local expertise will prove "invaluable", with Brazil being a key market for the company as it completes an operational reorganisation of its Mara Rosa mine and continues to progress Monte Do Carmo, a gold project in the next-door state to Mara Rosa.

Chief executive Eduardo Landin said: "I'm pleased to welcome Cassio to Hochschild. His extensive industry knowledge and strong local experience made him the clear choice for this role. We're excited to have him on board and look forward to his contributions he will bring in the years ahead.

"This is an important time for Hochschild as we focus on maximising the performance of our existing operations while advancing our key growth opportunities."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.